| JNJ | 6.81% | 243.20 | +0.25% | 3,096 | |
| AMGN | 4.02% | 375.25 | -0.46% | 1,174 | |
| EW | 4.01% | 85.15 | +1.06% | 5,166 | |
| ISRG | 3.99% | 489.91 | -0.74% | 870 | |
| MRK | 3.94% | 118.48 | +1.17% | 3,652 | |
| COR | 3.74% | 358.28 | -0.97% | 1,129 | |
| MCK | 3.71% | 936.70 | -0.58% | 421 | |
| GILD | 3.27% | 148.59 | +1.34% | 2,515 | |
| DHR | 3.12% | 196.40 | -1.21% | 1,648 | |
| IDXX | 3.03% | 607.34 | -0.51% | 507 |
BlackRock ETF Trust - iShares Health Innovation Active ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of global region. The fund invests directly and through derivatives in stocks of companies operating across health care, health care equipment and services, pharmaceuticals, biotechnology and life science, biotechnology, pharmaceuticals sectors. The fund invests in growth stocks of companies across diversified market capitalization. The fund seeks to benchmark the performance of its portfolio against MSCI ACWI Index (Net) and the STOXX Global Breakthrough Healthcare Index (Net). BlackRock ETF Trust - iShares Health Innovation Active ETF was formed on September 29, 2020 and is domiciled in the United States.